Evie Koslosky
Stock Analyst at Goldman Sachs
(0.73)
# 3,763
Out of 5,182 analysts
9
Total ratings
16.67%
Success rate
-6.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Neutral | $110 → $95 | $86.77 | +9.48% | 2 | Apr 14, 2026 | |
| DHR Danaher | Maintains: Buy | $265 → $230 | $177.25 | +29.76% | 2 | Apr 13, 2026 | |
| BRKR Bruker | Maintains: Sell | $40 → $35 | $36.55 | -4.24% | 2 | Feb 13, 2026 | |
| MTD Mettler-Toledo International | Initiates: Neutral | $1,475 | $1,282.45 | +15.01% | 1 | Dec 9, 2025 | |
| A Agilent Technologies | Initiates: Buy | $170 | $115.55 | +47.12% | 1 | Dec 9, 2025 | |
| TMO Thermo Fisher Scientific | Initiates: Buy | $685 | $469.71 | +45.83% | 1 | Dec 9, 2025 |
Revvity
Apr 14, 2026
Maintains: Neutral
Price Target: $110 → $95
Current: $86.77
Upside: +9.48%
Danaher
Apr 13, 2026
Maintains: Buy
Price Target: $265 → $230
Current: $177.25
Upside: +29.76%
Bruker
Feb 13, 2026
Maintains: Sell
Price Target: $40 → $35
Current: $36.55
Upside: -4.24%
Mettler-Toledo International
Dec 9, 2025
Initiates: Neutral
Price Target: $1,475
Current: $1,282.45
Upside: +15.01%
Agilent Technologies
Dec 9, 2025
Initiates: Buy
Price Target: $170
Current: $115.55
Upside: +47.12%
Thermo Fisher Scientific
Dec 9, 2025
Initiates: Buy
Price Target: $685
Current: $469.71
Upside: +45.83%